Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

ipos0_l

FDA approves Regeneron’s Evkeeza for HoFH

February 12, 2021 Medical Communications FDA, Regeneron

The FDA has approved Regeneron’s Evkeeza (evinacumab-dgnb) as an adjunct to other low-density lipoprotein cholesterol (LDL-C) lowering therapies to treat …
News

Arthritis drug tocilizumab cuts COVID-19 deaths in hospital trial

February 12, 2021 Medical Communications COVID-19

The rheumatoid arthritis drug tocilizumab can reduce the risk of death in severe COVID-19 patients and shorten the time spent …
News
elizabeth_crain

Exscientia appoints Moelis & Company COO Elizabeth Crain to Board of Directors

February 10, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

AI-driven pharma-tech company Exscientia has appointed Elizabeth Crain to their Board of Directors.
Appointment
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

February 5, 2021 Medical Communications COVID-19

In the last week, a number of COVID-19 vaccine developments have been made. Johnson & Johnson’s one-shot jab was found …
News
astrazeneca-sign

New Oxford University-AstraZeneca vaccine against COVID-19 mutations could be available by October

February 5, 2021 Medical Communications AstraZeneca, COVID-19

Oxford University and AstraZeneca could release a new vaccine by October in order to counter the new mutations of COVID-19 …
News
pfizer_building_logo1

Pfizer withdraws application for emergency vaccine authorisation in India

February 5, 2021 Medical Communications COVID-19, Pfizer

Pfizer has withdrawn its application in India for emergency use authorisation of its vaccine, which it has produced with German …
News
candida_albicans_248_35

Hyloris and Purna Female Healthcare partner to develop novel women’s health product

February 5, 2021 Medical Communications Hyloris, women

Hyloris Pharmaceuticals and Purna Female Healthcare (PFH), a spin-off founded by Purna Pharmaceuticals and Creafund, have entered into a partnership …
News
astrazeneca_sign_sky

AstraZeneca’s Imfinzi misses target in Phase III head and neck cancer trial

February 5, 2021 Medical Communications AstraZeneca, Cancer

AstraZeneca’s Imfinzi (durvalumab) has failed to improve overall survival (OS) for patients with recurrent or metastatic head and neck cancer …
News
mark_wilcox_002

Destiny Pharma appoints Professor Mark Wilcox to its Scientific Advisory Board

February 4, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Destiny Pharma, a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life threatening …
Appointment
caroline_oconnor

Raremark appoints Caroline O’Connor as CCO

February 4, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Raremark has appointed Caroline O’Connor as its new Chief Commercial Officer. Previously holding the position of Raremark’s Senior Vice President …
Appointment
philippe_dro

Scenic Biotech appoints Dr Philippe Dro as Chairman

February 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Scenic Biotech has announced the appointment of Dr Philippe Dro as its independent Chairman. Dr Dro replaces Dr Ulrich Grau, …
Appointment
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

January 29, 2021 Medical Communications

Most of Pharmafile.com’s top stories this week concern the approval of various treatments in the US, UK, and EU – …
News
astrazeneca-sign

AstraZeneca COVID-19 vaccine not for over 65s, German health body says

January 29, 2021 Medical Communications AstraZeneca, COVID-19

Germany’s main public health body has recommended that AstraZeneca’s COVID-19 vaccine is only administered to those aged between 18 and …
News
novavax

Novavax COVID-19 vaccine shows almost 90% efficacy in Phase III trial

January 29, 2021 Medical Communications COVID-19, Novavax

Novavax has announced that its COVID-19 vaccine candidate, NVX-CoV2373, demonstrated an efficacy of 89.3% in its UK Phase III trial. …
News
leiden

Toxys and Leiden University to commercialise and develop animal-free toxicity testing platform

January 29, 2021 Medical Communications Toxys

Toxys, Leiden University, and Leiden University Medical Center have agreed to commercialise and develop further the ToxProfiler technology invented at …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025